Pharmafile Logo
Pharmafocus logo
Advanced Search
jessica_fine

MSD UK appoints Jessica Fine as executive director of external affairs

December 16, 2015
Medical Communications Jessica Fine, MSD

MSD has appointed former Lexington Health boss Jessica Fine to lead its external affairs team in the UK from April …

Appointment

New final NICE guidance on AbbVie, BMS, Pfizer and Roche drugs

December 16, 2015
Sales and Marketing BioMarin Pharma, Enbrel, Humira, Ikervis, MPS IVa, NICE, NICE guidance, Orencia, RoActemra, Santen, apremilast, ciclosporin, dry eye syndrome, juvenile idiopathic arthritis, otezla, psoriatic arthritis, vimizin

NICE has published final guidance on several drugs, approving therapies for juvenile idiopathic arthritis, dry eye disease and Morquio A …

News
tony_gardiner

Avacta appoints Tony Gardiner as chief financial officer

December 16, 2015
Medical Communications Avacta Group

Avacta Group, the developer of Affimer biotherapeutics and research reagents, has appointed Tony Gardiner as group chief financial officer. Gardiner …

Appointment
Return on investment

Analysts say pharma R&D returns challenged by drag of high costs

December 16, 2015
Research and Development, Sales and Marketing R&D, drug development, research and development, return of investment, sales, sales forecasts

The projected rate of return on pharma industry research and development has more than halved since 2010, from 10.1% to …

News
juan_luciano

Juan Luciano appointed to Eli Lilly board

December 16, 2015
Medical Communications Eli Lilly

The board of directors of Eli Lilly has elected Juan Luciano as a new member, effective February 1 2016. Luciano …

Appointment

AstraZeneca to acquire Takeda’s respiratory franchise

December 16, 2015
Manufacturing and Production, Research and Development AstraZeneca, China, Takeda, investment, respiratory

AstraZeneca and Takeda have agreed a multi-million pound deal for AZ to acquire the Japanese firm’s core respiratory business, including …

News
clinical_trial-web

Pharma deals crucial to cutting R&D costs

December 16, 2015
Research and Development GlobalData, R&D, drug development, pharma, research and development

With the average cost of getting a novel drug to market at almost $2.5 billion, and few products achieving blockbuster …

News
Monopoly board tax

Pharma companies warned on patent box changes

December 16, 2015
Research and Development R&D, patent box, pharma, research and development, tax

Proposed Government changes to legislation will require businesses to track and trace all R&D expenditure if they want to continue …

News
R&D researcher

More breakthroughs in cancer pose the question: Who pays for them?

December 16, 2015
Research and Development Cancer, drug access, immunotherapy, oncology

The molecular revolution over the last decade has done much to help turn cancer into an illness that can be …

Feature
NHS sign

NICE rejects BMS cancer drug in draft guidance

December 16, 2015
Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, NHS, NICE, lung cancer, nivolumab, non small cell lung cancer, non-small cell lung cancer, opdivo

In draft guidance, NICE has chosen not to recommend Bristol-Myers Squibb’s Opdivo for the treatment of locally advanced or metastatic …

News
Kadcyla

NICE says no to NHS funding for Kadcyla

December 16, 2015
Research and Development, Sales and Marketing Breast Cancer Now, Kadcyla, NHS, NICE, Roche, advanced breast cancer, breast cancer

NICE has turned down Roche’s application for NHS funding for Kadcyla as a treatment for a type of advanced breast …

News

Precious Cells Group appoints David Huse in expansion push

December 15, 2015
Medical Communications, Research and Development Stem cells, precious cells group

Precious Cells Group, a UK-based international provider of stem cell storage and related technologies, has announced the appointment of commercial …

Appointment
amgen_hq

Amgen buys back rights to three drugs from GSK

December 15, 2015
Research and Development, Sales and Marketing Amgen, GSK

Amgen has announced that it will reacquire the rights to three products in 48 countries from GSK, as it seeks …

News
AZ Macclesfield site

AstraZeneca invests £75m to future-proof production facilities

December 15, 2015
Manufacturing and Production AstraZeneca, manufacturing, production

AstraZeneca says it will invest £75m to future-proof a key production facility in Macclesfield, Cheshire. The upgrade to the 48-year-old …

News
Sanofi BI logos

Pharma giants Sanofi and Boehringer negotiate deal to swap assets

December 15, 2015
Business Services, Manufacturing and Production, Sales and Marketing Andreas Barner, Boehringer, Boehringer Ingelheim, Merial, Sanofi, olivier brandicourt

Two of the world’s biggest pharma companies – Sanofi and Boehringer Ingelheim – have entered into exclusive negotiations to swap …

News
Malaria mosquito

GSK in malaria collaboration with Comic Relief

December 15, 2015
Manufacturing and Production Comic Relief, GSK, corporate social responsibility, csr, malaria

GSK and UK-based charity Comic Relief have launched a five-year partnership to fight malaria and improve health in five countries …

News

Bristol-Myers Squibb chooses UCLA as latest research partner

December 14, 2015
Manufacturing and Production, Research and Development BMS, Bristol-Myers Squibb, University of California Los Angeles, rare malignancies, ucla

Pharma firm Bristol-Myers Squibb is entered into a new collaboration agreement with the University of California Los Angeles (UCLA) as …

News
Ablynx CEO Edwin Moses

Ablynx sets focus on pharma collaborations

December 14, 2015
Manufacturing and Production, Research and Development Ablynx, collaboration, nanobodies, partnership

Drug development companies should prioritise strategic pharma collaborations to keep up with the next wave of immuno-oncology treatments, the chief …

News
personal-95715_640

Mirror. Signal. Merger. How to deal with a pharma takeover

December 14, 2015
Manufacturing and Production, Medical Communications, Sales and Marketing Deals, acquisition, buyouts, mergers, takeovers

So 2015 has been a record year for M&A in the pharma industry.The Financial Times has called this “the most …

Feature
AZ building

AstraZeneca in $5bn Acerta buyout talks

December 14, 2015
Sales and Marketing Acerta Pharma, AstraZeneca, acalabrutinib, acquisitions, blood cancer, buyout, chronic lymphocytic leukaemia, mergers, takeover

AstraZeneca has confirmed it is in negotiations to buy cancer drug developer Acerta Pharma BV for more than $5 billion …

News
The Gateway to Local Adoption Series

Latest content

SMC accepts amivantamab and lazertinib for EGFR-positive lung cancer

May 22, 2026

BioDuro and CTI Biotechnology in preclinical drug development partnership

May 21, 2026

Sygnature Discovery appoints Susanne Back as Head of In Vivo Pharmacology

May 21, 2026

NICE recommends sotatercept for pulmonary arterial hypertension

May 20, 2026

Vetter begins construction of new injectable medicines facility

May 20, 2026